Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from devastating and debilitating diseases with significant unmet medical need. The company has built a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune diseases.